Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy.
Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy. Br J Haematol. 2021 01; 192(2):e38-e42.